Retinal Vein Occlusion Terminated Phase 3 Trials for Bevacizumab (DB00112)

Also known as: Occlusion Retinal Vein / Retinal-vein occlusion / Retinal Vein Occlusions(RVO) / Retinal Vein Occlusion (RVO) / Retinal Vein Occlusions

IndicationStatusPhase
DBCOND0000674 (Retinal Vein Occlusion)Terminated3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03203447Suprachoroidal Injection of Triamcinolone Acetonide With IVT Anti-VEGF in Subjects With Macular Edema Following RVOTreatment